SpringWorks Therapeutics Inc
NASDAQ:SWTX

Watchlist Manager
SpringWorks Therapeutics Inc Logo
SpringWorks Therapeutics Inc
NASDAQ:SWTX
Watchlist
Price: 49.77 USD -2.18% Market Closed
Market Cap: 3.7B USD

Intrinsic Value

The intrinsic value of one SWTX stock under the Base Case scenario is 45 USD. Compared to the current market price of 49.77 USD, SpringWorks Therapeutics Inc is Overvalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SWTX Intrinsic Value
45 USD
Overvaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
SpringWorks Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
SWTX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SWTX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

SpringWorks Therapeutics Inc
NASDAQ:SWTX
US
Biotechnology
Market Cap
3.7B USD
IPO
Sep 13, 2019
US
Biotechnology
Market Cap
3.7B USD
IPO
Sep 13, 2019
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SWTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about SpringWorks Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
SpringWorks Therapeutics Inc

Current Assets 380.5m
Cash & Short-Term Investments 308m
Receivables 46.2m
Other Current Assets 26.2m
Non-Current Assets 206.8m
Long-Term Investments 158.1m
PP&E 26.7m
Other Non-Current Assets 22m
Efficiency

Free Cash Flow Analysis
SpringWorks Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
SpringWorks Therapeutics Inc

Revenue
191.6m USD
Cost of Revenue
-12.6m USD
Gross Profit
179m USD
Operating Expenses
-457.2m USD
Operating Income
-278.1m USD
Other Expenses
20m USD
Net Income
-258.1m USD
Fundamental Scores

SWTX Profitability Score
Profitability Due Diligence

SpringWorks Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
28/100
Profitability
Score

SpringWorks Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

SWTX Solvency Score
Solvency Due Diligence

SpringWorks Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

SpringWorks Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SWTX Price Targets Summary
SpringWorks Therapeutics Inc

Wall Street analysts forecast SWTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SWTX is 75.77 USD with a low forecast of 65.65 USD and a high forecast of 91.35 USD.

Lowest
Price Target
65.65 USD
32% Upside
Average
Price Target
75.77 USD
52% Upside
Highest
Price Target
91.35 USD
84% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

SpringWorks Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SWTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SWTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SWTX stock?

The intrinsic value of one SWTX stock under the Base Case scenario is 45 USD.

Is SWTX stock undervalued or overvalued?

Compared to the current market price of 49.77 USD, SpringWorks Therapeutics Inc is Overvalued by 10%.

Back to Top